Skip to main content

Gene Logic and Affy Amend Terms of Microarray Supply Agreement; Subscription Payment to Affy Slashed

NEW YORK, Dec. 30 (GenomeWeb News) - Gene Logic yesterday announced amendments to its 2002 microarray supply agreement with Affymetrix.


In an SEC filing, Gene Logic said that it will pay Affymetrix a mere $500,000 in annual subscription fees in 2005, instead of $4 million that it paid in prior years.


Gene Logic also said it will purchase at least $500,000 worth of Affymetrix products and services this month, and at least another $9.5 million in 2005.


The companies will also establish pricing for probe array products for the period between July 1, 2003 and Dec. 31, 2005.


The original contract, effective since Jan. 1, 2002, sets the terms for supplying Gene Logic and its subsidiaries with DNA probe arrays from Affymetrix for developing database products and services. That agreement, disclosed in a 2002 SEC filing by Gene Logic, did not provide any financial details.


The two companies first announced a supply agreement in January of 1999, which the 2002 agreement replaced.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.